TXG:NSD-10X Genomics Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 20.02

Change

+0.41 (+2.09)%

Market Cap

N/A

Volume

0.96M

Analyst Target

USD 120.25
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+1.54 (+1.71%)

USD 42.11B
TEM Tempus AI, Inc. Class A Common..

+3.98 (+8.13%)

USD 7.92B
HQY HealthEquity Inc

+4.91 (+6.28%)

USD 6.98B
RCM R1 RCM Inc

+0.01 (+0.07%)

USD 5.98B
WAY Waystar Holding Corp. Common S..

+0.23 (+0.86%)

USD 4.47B
GDRX Goodrx Holdings Inc

+0.21 (+3.05%)

USD 2.57B
BTSG BrightSpring Health Services, ..

+0.04 (+0.27%)

USD 2.52B
PRVA Privia Health Group Inc

+0.24 (+1.38%)

USD 2.16B
PINC Premier Inc

+0.09 (+0.47%)

USD 2.00B
OMCL Omnicell Inc

+0.88 (+2.12%)

USD 1.98B

ETFs Containing TXG

ARKG:LSE ARK Genomic Revolution UC.. 4.13 % 0.00 %

+0.02 (+0.43%)

USD 2.96M
ARCG:LSE ARK Genomic Revolution UC.. 4.00 % 0.00 %

+2.05 (+0.43%)

USD 2.87M
SGDM Sprott Gold Miners ETF 3.93 % 0.57 %

-0.05 (0.43%)

USD 0.28B
ARKG 0.00 % 0.75 %

N/A

N/A
FDTS First Trust Developed Mar.. 0.00 % 0.80 %

+0.38 (+0.43%)

USD 8.89M
PZC:CA 0.00 % 0.67 %

N/A

N/A
GOAU U.S. Global GO GOLD and P.. 0.00 % 0.60 %

+0.01 (+0.43%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -64.22% 17% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.22% 17% F 10% F
Trailing 12 Months  
Capital Gain -48.23% 38% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.23% 38% F 17% F
Trailing 5 Years  
Capital Gain -61.09% 32% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.09% 26% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain 8.39% N/A N/A 64% D
Dividend Return 8.39% N/A N/A 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 77.85% N/A N/A 22% F
Risk Adjusted Return 10.77% N/A N/A 47% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike